Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
M. L. Hull, B. Stuckey, K. Hartman, N. Zack, A. Thurman & D. R. Friend. (2023) Safety and acceptability of intravaginal rings releasing estradiol and progesterone. Climacteric 26:5, pages 465-471.
Read now
Read now
Stephanie Meier, Beth Sundstrom, Andrea L. DeMaria & Cara Delay. (2019) Beyond a Legacy of Coercion: Long-Acting Reversible Contraception (LARC) and Social Justice. Women's Reproductive Health 6:1, pages 17-33.
Read now
Read now
Beth Sundstrom, Andrea L. DeMaria, Stephanie Meier, Annabel Jones & Grace E. Moxley. (2015) “It Makes You Rethink Your Choice of the Pill”: Theory-Based Formative Research to Design a Contraceptive Choice Campaign. Journal of Health Communication 20:11, pages 1346-1354.
Read now
Read now
Iñaki Lete, Maialen Pérez de Arrilucea, María Rodríguez & Eskerne Bello. (2014) Efficacy, safety, and patient acceptability of the etonogestrel and ethinyl estradiol vaginal ring. Open Access Journal of Contraception 5, pages 39-48.
Read now
Read now
Simona Palm-Fischbacher & Ulrike Ehlert. (2014) Dispositional resilience as a moderator of the relationship between chronic stress and irregular menstrual cycle. Journal of Psychosomatic Obstetrics & Gynecology 35:2, pages 42-50.
Read now
Read now
Rossella E. Nappi. (2013) Counseling on vaginal delivery of contraceptive hormones: implications for women’s body knowledge and sexual health. Gynecological Endocrinology 29:12, pages 1015-1021.
Read now
Read now
Frans J. M. E. Roumen & Daniel R. Mishell$suffix/text()$suffix/text(). (2012) The contraceptive vaginal ring, NuvaRing®, a decade after its introduction. The European Journal of Contraception & Reproductive Health Care 17:6, pages 415-427.
Read now
Read now
Devorah R Wieder & Lynn Pattimakiel. (2010) Examining the efficacy, safety, and patient acceptability of the combined contraceptive vaginal ring (NuvaRing®). International Journal of Women's Health 2, pages 401-409.
Read now
Read now
Gabriele S. Merki-Feld & Martin Hund. (2010) Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. The European Journal of Contraception & Reproductive Health Care 15:6, pages 413-422.
Read now
Read now
Frans JME Roumen. (2008) Etonogestrel–ethinylestradiol vaginal ring for hormonal contraception. Expert Review of Obstetrics & Gynecology 3:6, pages 705-714.
Read now
Read now
Articles from other publishers (28)
Kathleen Ridgeway, Elizabeth T. Montgomery, Kevin Smith, Kristine Torjesen, Ariane van der Straten, Sharon L. Achilles & Jennifer B. Griffin. (2022) Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world. Contraception 106, pages 16-33.
Crossref
Crossref
Cameron James Parkin, Sally Beath & Krishan Rasiah. (2021)
A
NuvaRing
caught in the wrong spot
. ANZ Journal of Surgery 92:1-2, pages 259-262.
Crossref
Crossref
Thérèse Delvaux, Vicky Jespers, Lenka Benova & Janneke van de Wijgert. (2021) Acceptability and Satisfaction of Contraceptive Vaginal Rings in Clinical Studies: A Systematic Review and Narrative Synthesis. Frontiers in Global Women's Health 2.
Crossref
Crossref
Kirsten I. Black, Kevin McGeechan, Cathy J. Watson, Jayne Lucke, Angela Taft, Kathleen McNamee, Marion Haas, Jeffrey F. Peipert & Danielle Mazza. (2021) Women’s satisfaction with and ongoing use of hormonal long‐acting methods compared to the oral contraceptive pill: Findings from an Australian general practice cluster randomised trial (ACCORd). Australian and New Zealand Journal of Obstetrics and Gynaecology 61:3, pages 448-453.
Crossref
Crossref
Natalie M. Williams, Michael Randolph, Ali Rajabi-Estarabadi, Jonette Keri & Antonella Tosti. (2020) Hormonal Contraceptives and Dermatology. American Journal of Clinical Dermatology 22:1, pages 69-80.
Crossref
Crossref
A. Z. Khashukoeva, S. A. Khlynova, S. B. Kerchelaeva & M. V. Burdenko. (2020) Vaginal hormonal ring: a modern method for prolonged contraception. Meditsinskiy sovet = Medical Council:3, pages 61-66.
Crossref
Crossref
Beth Sundstrom, Deborah Billings, Ellie Smith, Merissa Ferrara, Bill Albert & Katherine Suellentrop. (2019) Evaluating the Whoops Proof S.C. Campaign: A Pair-Matched Group Pretest–Posttest Quasi-experimental Study. Maternal and Child Health Journal 23:8, pages 1036-1047.
Crossref
Crossref
Michelle C. Fox, Christine Klipping, Allison Martin Nguyen, Tara L. Frenkl, Sandra M. Cruz, Yinna Wang & Tjeerd Korver. (2019) A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea. Contraception 99:2, pages 125-130.
Crossref
Crossref
Saumya RamaRao, Francis Obare, Salisu Ishaku, Babacar Mané, Heather Clark, Wilson Liambila, Godwin Unumeri, Harriet Birungi, Nafissatou Diop, Deepa Rajamani & John Townsend. (2018) Do Women Find the Progesterone Vaginal Ring Acceptable? Findings from Kenya, Nigeria, and Senegal. Studies in Family Planning 49:1, pages 71-86.
Crossref
Crossref
Ian Major & Christopher McConville. (2017) Vaginal drug delivery for the localised treatment of cervical cancer. Drug Delivery and Translational Research 7:6, pages 817-828.
Crossref
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy V. Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2017) No 329-Consensus canadien sur la contraception (4e partie de 4) : chapitre 9 – contraception hormonale combinée. Journal of Obstetrics and Gynaecology Canada 39:4, pages 269-314.e5.
Crossref
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy V. Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2017) No. 329-Canadian Contraception Consensus Part 4 of 4 Chapter 9: Combined Hormonal Contraception. Journal of Obstetrics and Gynaecology Canada 39:4, pages 229-268.e5.
Crossref
Crossref
Robert Feldman, Tara L. Frenkl, Carol Yacik, Yinna Wang & Michelle C. Fox. (2016) Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study. Contraception 94:4, pages 362-365.
Crossref
Crossref
Marie-Soleil Wagner & Amanda Black. (2016) The Combined Contraceptive Vaginal Ring: an Update. Current Obstetrics and Gynecology Reports 5:1, pages 1-12.
Crossref
Crossref
Kate Morrow Guthrie, Sara Vargas, Julia G. Shaw, Rochelle K. Rosen, Jacob J. van den Berg, Patrick F. Kiser, Karen Buckheit, Dana Bregman, Lara Thompson, Kathleen Jensen, Todd Johnson & Robert W. Buckheit. (2015) The Promise of Intravaginal Rings for Prevention: User Perceptions of Biomechanical Properties and Implications for Prevention Product Development. PLOS ONE 10:12, pages e0145642.
Crossref
Crossref
Kumiyo Inoue, Alexandra Barratt & Juliet Richters. (2015) Does research into contraceptive method discontinuation address women's own reasons? A critical review. Journal of Family Planning and Reproductive Health Care 41:4, pages 292-299.
Crossref
Crossref
Sophia G. Antimisiaris & Spyridon Mourtas. (2015) Recent advances on anti-HIV vaginal delivery systems development. Advanced Drug Delivery Reviews 92, pages 123-145.
Crossref
Crossref
Christopher McConville. (2015) The therapeutic potential of vaginal drug delivery in the treatment of cervical cancer. Therapeutic Delivery 6:5, pages 559-570.
Crossref
Crossref
Peter Boyd, Ian Major, Weiguang Wang & Christopher McConville. (2014) Development of disulfiram-loaded vaginal rings for the localised treatment of cervical cancer. European Journal of Pharmaceutics and Biopharmaceutics 88:3, pages 945-953.
Crossref
Crossref
Ruth B. Merkatz, Marlena Plagianos, Elena Hoskin, Michael Cooney, Paul C. Hewett & Barbara S. Mensch. (2014) Acceptability of the nestorone?/ethinyl estradiol contraceptive vaginal ring: development of a model; implications for introduction. Contraception 90:5, pages 514-521.
Crossref
Crossref
Lauren B. Zapata, Maria W. Steenland, Dalia Brahmi, Polly A. Marchbanks & Kathryn M. Curtis. (2013) Effect of missed combined hormonal contraceptives on contraceptive effectiveness: a systematic review. Contraception 87:5, pages 685-700.
Crossref
Crossref
Christopher McConville, Ian Major, David R. Friend, Meredith R. Clark & R. Karl Malcolm. (2012) Development of a UC781 releasing polyethylene vinyl acetate vaginal ring. Drug Delivery and Translational Research 2:6, pages 489-497.
Crossref
Crossref
Beth Sundstrom. (2012) Fifty years on “the pill”: a qualitative analysis of nondaily contraceptive options. Contraception 86:1, pages 4-11.
Crossref
Crossref
Christopher Mc Conville, Ian Major, David R. Friend, Meredith R. Clark, A. David Woolfson & R. Karl Malcolm. (2012) Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings. Journal of Biomedical Materials Research Part B: Applied Biomaterials 100B:4, pages 891-895.
Crossref
Crossref
Kelsey A. Petrie, Anu H. Torgal & Carolyn L. Westhoff. (2011) Matched-pairs analysis of ovarian suppression during oral vs. vaginal hormonal contraceptive use. Contraception 84:5, pages e1-e4.
Crossref
Crossref
Lekeisha R. Terrell, Amanda E. Tanner, Devon J. Hensel, Margaret J. Blythe & J. Dennis Fortenberry. (2011) Acceptability of the Vaginal Contraceptive Ring Among Adolescent Women. Journal of Pediatric and Adolescent Gynecology 24:4, pages 204-210.
Crossref
Crossref
Sarah Maheux-Lacroix, Mathieu Leboeuf, Alexandra Dufresne & Sylvie Dodin. (2011) Adolescents’ Willingness to Use the Contraceptive Vaginal Ring. Journal of Obstetrics and Gynaecology Canada 33:4, pages 353-360.
Crossref
Crossref
Noa'a Shimoni & Carolyn Westhoff. (2008) Review of the vaginal contraceptive ring (NuvaRing<SUP>®</SUP>). Journal of Family Planning and Reproductive Health Care 34:4, pages 247-250.
Crossref
Crossref